One more stock that's already starting to trigger a big breakout trade today is Galena Biopharma (GALE), a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using RNAi-targeted and immunotherapy technologies. This yet another hot stock in 2012, with shares up over a whopping 196%.
If you look at the chart for Galena Biopharma, you'll notice that this stock hit a recent low at 36 cents per share back in December. Since hitting that low, the stock has soared to its current price of around $1.40 a share. During that monster uptrend, shares of Galena Biopharma have consistently made higher lows and higher highs, which is bullish price action. The stock has also seen strong upside volume trends, which is bullish technical action. Now GALE is starting to trigger a big breakout trade today on strong volume.
Market players should continue to look for long-biased trades in GALE as long as the stock is trending near or above its key breakout levels of $1.39 to $1.48 a share. At last check, this stock has hit a daily high of $1.48 and volume is already over 2.8 million shares, which is well above its three-month average action of 818,074 shares. If this stock can manage to close near its daily highs and above those breakout levels, then it has a great chance to re-test its next major overhead resistance levels at $1.65 to $2.14 a share or possibly much higher very quickly.This is another heavily shorted stock, since the current short interest as a percentage of the float for GALE stands at 11%. The bears have also been increasing their short positions from the last reporting period by 52.6%, or by about 1.52 million shares. Look for a monster short-squeeze to kick off if GALE can hold the breakout. I also featured Galena recently in "5 Stocks Under $5 Making Big Moves." To see more breakout candidates, includingConceptus (CPTS), Sun Healthcare Group (SUNH) and Open Table (OPEN), check out the Breakout Stocks of the Week portfolio on Stockpickr. -- Written by Roberto Pedone in Winderemere, Fla.
Twitter and become a fan on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV